Induction immunosuppression in hepatitis C virus-infected liver transplant recipients.

Abstract

Liver TransplantationVolume 8, Issue 10B p. s44-s46 Debate I—Immunosuppression Of Hepatitis CFree Access Induction immunosuppression in hepatitis C virus–infected liver transplant recipients Michael R. Lucey MD, Corresponding Author Michael R. Lucey MD Professor of Medicine [email protected] Section of Gastroenterology and Hepatology, University of Wisconsin–Madison, Madison, WIUniversity of Wisconsin–Madison, 600 Highland Ave, Rm H6/516 Clinical Science Center, Madison, WI 53792. Telephone: 608-263-7322; FAX: 608-265-5677Search for more papers by this author Michael R. Lucey MD, Corresponding Author Michael R. Lucey MD Professor of Medicine [email protected] Section of Gastroenterology and Hepatology, University of Wisconsin–Madison, Madison, WIUniversity of Wisconsin–Madison, 600 Highland Ave, Rm H6/516 Clinical Science Center, Madison, WI 53792. Telephone: 608-263-7322; FAX: 608-265-5677Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jlts.2002.35854Citations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889– 896. 2 Delves PJ, Roitt IM. The immune system—The first of two parts. N Engl J Medicine 2000; 343: 37– 49. 3 Delves PJ, Roitt IM. The immune system—The second of two parts. N Engl J Medicine 2000; 343: 108– 117. 4 Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823– 830. 5 Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997: 92: 1453– 1457. 6 Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, et al. Hepatitis C kinetics during and immediately after transplantation. Hepatology 2002; 35: 680– 687. 7 Neuhaus P, Clavien PA, Kittur D, Salizzoni M, Rimola A, Abeywickrama K, et al. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trial. Liver Transpl 2002; 8: 132– 142. 8 Calmus Y, Scheele JR, Gonzalez-Pinto I, Jaurrieta EJ, Klar E, Pageaux GP, et al. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Liver Transpl 2002; 8: 123– 131. 9 Eckhoff DE, McGuire B, Sellers M, Contreras J, Frenette L, Young C, et al. The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. Transplantation 2000; 69: 1867– 1872. 10 Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG. Experience with daclizumab in liver transplantation: Renal transplantation dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation 2000; 69: 307– 311. 11 Washburn K, Tourtellot C, Maxwell P, Halff G. Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. Transplantation 2001; 72: 1675– 1679. 12 Eason JK, Loss GE, Blazek J, Nair S, Mason AL. Steroid-free transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial. Liver Transpl 2001; 7: 698– 700. Citing Literature Volume8, Issue10BSupplement: Liver Transplantation for Viral Hepatitis From the November 1,2002, AASLD/ILTS Transplant Course Sheraton Hotel, Boston, MAOctober 2002Pages s44-s46 ReferencesRelatedInformation